STEM has spent nearly two decades supporting pharma companies with strategic insights. As Adam Boucher explained, the emergence of generative AI has opened new possibilities for analysing field ...

The venture capital firm backed the health technology company developing adhesive biosensors as alternatives to conventional fitness tracking devices.